Debate is still on-going regarding the potential effects of renin-angiotensin system inhibitors, such as angiotensin-converting enzyme (ACE) inhibitors or angiotensin II-receptor antagonists (ARBs), on the development of anaemia in patients with renal disease [11]. The gene discussed is REN; the disease is anemia.